Lexaria Bioscience Corp Stock Revenue Per Share

LEXX Stock

USD 2.08 0.08 3.70%

Lexaria Bioscience Corp fundamentals help investors to digest information that contributes to Lexaria Bioscience's financial success or failures. It also enables traders to predict the movement of Lexaria Stock. The fundamental analysis module provides a way to measure Lexaria Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lexaria Bioscience stock.

		Last Reported	Projected for Next Year
	Revenue Per Share	0.04	0.04

Revenue Per Share is likely to rise to 0.04 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Lexaria Bioscience Corp Company Revenue Per Share Analysis

Lexaria Bioscience's Revenue per Share is a ratio of total revenue earned per one share of common stock over a single fiscal year. It is calculated by dividing sales revenue earned over 12 months by the average number of outstanding shares. Revenue used in the calculation of this ratio is typically recorded when cash or cash equivalents are exchanged for services or goods.

Current Lexaria Bioscience Revenue Per Share

0.0427

Most of Lexaria Bioscience's fundamental indicators, such as Revenue Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lexaria Bioscience Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Lexaria Revenue Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Lexaria Bioscience is extremely important. It helps to project a fair market value of Lexaria Stock properly, considering its historical fundamentals such as Revenue Per Share. Since Lexaria Bioscience's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Lexaria Bioscience's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Lexaria Bioscience's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Net Receivables	Short Term Debt	Intangible Assets	Net Tangible Assets	Net Invested Capital	Net Working Capital	Property Plant Equipment	Short Term Investments	Capital Stock	Long Term Debt	Short Long Term Debt
Total Assets		0.99	-0.9	-0.66	0.51	0.31	0.95	-0.55	-0.54	0.49	-0.19	0.67	0.86	0.82	0.69	0.54	0.75	-0.81	-0.49	-0.49
Total Stockholder Equity	0.99		-0.95	-0.69	0.46	0.16	0.98	-0.51	-0.6	0.46	-0.28	0.7	0.89	0.86	0.73	0.56	0.81	-0.83	-0.45	-0.45
Net Debt	-0.9	-0.95		0.68	-0.43	0.1	-0.99	0.38	0.55	-0.36	0.42	-0.68	-0.86	-0.84	-0.72	-0.54	-0.79	0.79	0.43	0.43
Retained Earnings	-0.66	-0.69	0.68		-0.68	-0.12	-0.71	0.29	0.48	-0.39	0.59	-0.93	-0.65	-0.36	-0.15	-0.74	-0.34	0.84	0.6	0.6
Accounts Payable	0.51	0.46	-0.43	-0.68		0.54	0.5	-0.4	0.07	-0.02	-0.2	0.46	0.34	0.04	-0.19	0.31	-0.09	-0.59	-0.94	-0.94
Total Liab	0.31	0.16	0.1	-0.12	0.54		0.05	-0.44	0.16	0.15	0.39	0.03	0.05	-0.09	-0.19	-0.02	-0.18	-0.17	-0.47	-0.47
Total Current Assets	0.95	0.98	-0.99	-0.71	0.5	0.05		-0.45	-0.55	0.41	-0.37	0.7	0.87	0.84	0.7	0.56	0.78	-0.82	-0.49	-0.49
Common Stock	-0.55	-0.51	0.38	0.29	-0.4	-0.44	-0.45		0.59	0.15	-0.32	-0.32	-0.65	-0.49	-0.41	0.03	-0.4	0.72	0.33	0.33
Current Deferred Revenue	-0.54	-0.6	0.55	0.48	0.07	0.16	-0.55	0.59		-0.26	0.2	-0.63	-0.8	-0.72	-0.7	-0.34	-0.77	0.75	-0.13	-0.13
Net Receivables	0.49	0.46	-0.36	-0.39	-0.02	0.15	0.41	0.15	-0.26		-0.2	0.48	0.32	0.39	0.35	0.63	0.47	-0.21	0.02	0.02
Short Term Debt	-0.19	-0.28	0.42	0.59	-0.2	0.39	-0.37	-0.32	0.2	-0.2		-0.47	-0.26	-0.18	-0.1	-0.44	-0.21	0.31	0.19	0.19
Intangible Assets	0.67	0.7	-0.68	-0.93	0.46	0.03	0.7	-0.32	-0.63	0.48	-0.47		0.72	0.44	0.3	0.81	0.48	-0.82	-0.33	-0.33
Net Tangible Assets	0.86	0.89	-0.86	-0.65	0.34	0.05	0.87	-0.65	-0.8	0.32	-0.26	0.72		0.84	0.76	0.46	0.85	-0.88	-0.23	-0.23
Net Invested Capital	0.82	0.86	-0.84	-0.36	0.04	-0.09	0.84	-0.49	-0.72	0.39	-0.18	0.44	0.84		0.96	0.35	0.96	-0.65	-0.09	-0.09
Net Working Capital	0.69	0.73	-0.72	-0.15	-0.19	-0.19	0.7	-0.41	-0.7	0.35	-0.1	0.3	0.76	0.96		0.21	0.96	-0.48	0.16	0.16
Property Plant Equipment	0.54	0.56	-0.54	-0.74	0.31	-0.02	0.56	0.03	-0.34	0.63	-0.44	0.81	0.46	0.35	0.21		0.42	-0.48	-0.27	-0.27
Short Term Investments	0.75	0.81	-0.79	-0.34	-0.09	-0.18	0.78	-0.4	-0.77	0.47	-0.21	0.48	0.85	0.96	0.96	0.42		-0.6	0.09	0.09
Capital Stock	-0.81	-0.83	0.79	0.84	-0.59	-0.17	-0.82	0.72	0.75	-0.21	0.31	-0.82	-0.88	-0.65	-0.48	-0.48	-0.6		0.52	0.52
Long Term Debt	-0.49	-0.45	0.43	0.6	-0.94	-0.47	-0.49	0.33	-0.13	0.02	0.19	-0.33	-0.23	-0.09	0.16	-0.27	0.09	0.52		1.0
Short Long Term Debt	-0.49	-0.45	0.43	0.6	-0.94	-0.47	-0.49	0.33	-0.13	0.02	0.19	-0.33	-0.23	-0.09	0.16	-0.27	0.09	0.52	1.0

Click cells to compare fundamentals

Lexaria Revenue Per Share Historical Pattern

Today, most investors in Lexaria Bioscience Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Lexaria Bioscience's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Lexaria Bioscience revenue per share as a starting point in their analysis.

Lexaria Bioscience Revenue Per Share

Timeline

Revenue per share does not take into account any of company expenses and is helpful only when comparing relative sale figures within a given industry.

Competition

Predict Lexaria Bioscience

Revenue Per Share Over Time

Lexaria Common Stock Shares Outstanding

Common Stock Shares Outstanding

13 Million

At this time, Lexaria Bioscience's Common Stock Shares Outstanding is fairly stable compared to the past year.

Lexaria Revenue Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lexaria Bioscience's direct or indirect competition against its Revenue Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lexaria Bioscience could also be used in its relative valuation, which is a method of valuing Lexaria Bioscience by comparing valuation metrics of similar companies.

Lexaria Bioscience is currently under evaluation in revenue per share category among its peers.

Lexaria Bioscience Current Valuation Drivers

We derive many important indicators used in calculating different scores of Lexaria Bioscience from analyzing Lexaria Bioscience's financial statements. These drivers represent accounts that assess Lexaria Bioscience's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Lexaria Bioscience's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	12.4M	27.3M	17.4M	6.9M	48.4M	115.2M
Enterprise Value	11.3M	16.5M	11.7M	5.8M	42.1M	116.4M

Lexaria Bioscience ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Lexaria Bioscience's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Lexaria Bioscience's managers, analysts, and investors.

Environmental

Governance

Social

Lexaria Fundamentals

	Return On Equity	-0.71
	Return On Asset	-0.38
	Operating Margin	(20.75) %
	Current Valuation	32.68 M
	Shares Outstanding	17.45 M
	Shares Owned By Insiders	7.00 %
	Shares Owned By Institutions	6.00 %
	Number Of Shares Shorted	298.17 K
	Price To Book	4.86 X
	Price To Sales	95.11 X
	Revenue	464.28 K
	Gross Profit	183.56 K
	EBITDA	(5.75 M)
	Net Income	(5.81 M)
	Cash And Equivalents	7.34 M
	Cash Per Share	1.23 X
	Total Debt	137.37 K
	Debt To Equity	0.01 %
	Current Ratio	40.09 X
	Book Value Per Share	0.64 X
	Cash Flow From Operations	(4.96 M)
	Short Ratio	2.34 X
	Earnings Per Share	(0.47) X
	Target Price	10.0
	Beta	1.06
	Market Capitalization	39.09 M
	Total Asset	8.87 M
	Retained Earnings	(51.56 M)
	Working Capital	1.93 M
	Net Asset	8.87 M

About Lexaria Bioscience Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Lexaria Bioscience Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lexaria Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lexaria Bioscience Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC